Researchers have reported that administration of granulocyte colony-stimulating factor, a drug that releases stem cells from the bone marrow into the blood, is unlikely to put healthy stem cell donors ...
Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies 73% (11 of 15) of ...
Patients with a diagnosis of symptomatic multiple myeloma receiving initial treatment with a lenalidomide-based treatment regimen started ⩽12 months prior to registration were enrolled. Patients ...
— MGTA-145 first-line mobilization program to move into Phase 2 studies in autologous and allogeneic patients in 2020, including allogeneic study in newly announced collaboration with National Marrow ...
Contribution of constitutive activation of Akt to the pathogenesis of mantle cell lymphoma (MCL) independent of PTEN protein expression No significant financial relationships to disclose. This is an ...
Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. The median WBC and ...
An intervention combining passive joint mobilization to realign the patellar (kneecap) position, along with exercise to maintain it, can reduce pain and improve function and quality in life in ...
(WASHINGTON, August 11, 2011) – According to a study published in Blood, the Journal of the American Society of Hematology (ASH), researchers have reported that administration of granulocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results